High blood pressure, or hypertension, affects nearly 1 in 3 adults globally and is a leading cause of stroke, heart disease, kidney failure, and premature death. Although pills are filling the typical treatment charts, increasing research and some innovative practitioners are calling for a life-style-based approach to treating, and even reversing, hypertension.

Introducing so-called the MAP Formula Mumbai doctor Dr. Pramod Tripathi went on Instagram to post his three-step lifestyle plan purporting to reduce blood pressure naturally by targeting its underlying biological causes, not merely symptoms. He claims that more than 1,350 individuals have already quit taking their blood pressure medication following his regimen. But what on earth is this MAP formula—and does it stand up to scientific review?

What Is the MAP Formula for High Blood Pressure?

Dr. Tripathi’s approach to blood pressure management focuses on three interconnected lifestyle strategies- Magnesium intake, Abdominal breathing, and Prolonged fasting. Each targets different but related mechanisms that influence vascular tone, nervous system balance, and insulin resistance, all of which play key roles in hypertension.

High blood pressure may be one of the most common chronic conditions today, but it doesn’t have to be a permanent one. Dr. Tripathi’s MAP formula offers a simple, structured, and science-backed approach that empowers people to take control of their health naturally. The formula is straightforward- M: Magnesium-rich diet and supplements, A: Abdominal breathing for nervous system balance and P: Prolonged fasting to lower insulin and improve vascular health

M: Magnesium

Magnesium is involved in more than 300 biochemical reactions in the body, and its role in affecting the blood pressure is well established that helps to relax the blood.

Magnesium relaxes blood vessels, reduces vascular resistance, and improves circulation. Those who suffer from hypertension have a lower magnesium level that causes constriction of the vessels and results in increased pressure. Dr. Tripathi suggests there are better natural sources of magnesium -

• Pumpkin seeds, one of the richest food sources
• Green leafy vegetables, particularly when mixed into chlorophyll-dense green smoothies
• Magnesium glycinate supplements (200 mg), which are gentle on the stomach and extremely bioavailable

A 2021 meta-analysis in the American Heart Association journal Hypertension reaffirmed that magnesium supplementation can substantially lower systolic as well as diastolic blood pressure, particularly in individuals with magnesium deficiency or insulin resistance.

A: Abdominal Breathing

The majority of individuals with hypertension, Dr. Tripathi says, breathe incorrectly—shallow, fast chest breathing that places the body in a state of sympathetic overdrive (the "fight-or-flight" state) all the time. The autonomic nervous system has two divisions:

• The sympathetic system, which increases blood pressure and heart rate
• The parasympathetic system, which encourages relaxation and decreases blood pressure

Chest breathing can turn on the sympathetic system, but abdominal (diaphragmatic) breathing can help turn on the parasympathetic system, slowing down the heart, decreasing cortisol, and lowering blood pressure naturally.

Taking 3–5 slow belly breaths per hour can seem easy, yet research indicates even that minimal change can produce quantifiable changes in blood pressure, mood, and stress tolerance.

Dr. Tripathi also invites the audience to practice yogic breathing exercises, a lot of which are available freely through guided videos on sites such as YouTube. The trick is persistence, daily breathing forms a nervous system reset after some time.

P: Prolonged Fasting

The last and most important pillar of the MAP formula, as cited by Dr. Tripathi, is Prolonged Fasting (PF). Insulin isn't only a blood sugar hormone—it also plays an unseen but significant role in blood pressure control. Elevated insulin levels, commonly found in individuals with insulin resistance or type 2 diabetes, cause:

• Sodium retention, which raises blood volume
• Overactivity of the sympathetic nervous system, increasing blood pressure
• Vascular damage, decreasing their elasticity and elevating vascular resistance

Briefly, hyperinsulinemia (excess insulin) is a stealthy cause of diabetes and hypertension.

Extended fasting—fasts for 48 hours or more under medical supervision—can sharply decrease insulin levels, allowing the body time to restore insulin sensitivity and regulate hormone balance. Dr. Tripathi reports that this treatment has caused more than a thousand patients to discontinue their blood pressure medication altogether.

It's not merely anecdotal, an increasing body of peer-reviewed research, including a 2022 paper in Cell Metabolism, does seem to indicate that intermittent and longer-term fasting can help lower systolic blood pressure, enhance insulin sensitivity, and reduce inflammation.

Nevertheless, longer-term fasting is not for everyone and must be done with caution, particularly by individuals with ongoing illnesses, medical guidance being paramount.

Can the MAP Formula Substitute Medicine?

Dr. Tripathi is not guaranteeing miracles—but he is indicating that for many, high blood pressure is a reversible condition, not a lifetime sentence. The focus on root causes of the MAP formula—nutrient deficiency, stress response, and insulin resistance—makes it an attractive addition to conventional methods.

However, medical professionals caution against it. Experts state that although magnesium, stress reduction, and dietary interventions such as fasting can definitely be beneficial, patients must not stop medications cold turkey. Collaborate with a doctor in reducing dosages if blood pressure is brought under control.

That being said, an overall lifestyle regimen such as the MAP formula—potentially could reduce patients' reliance on medication or arrest the disease's advancement toward more severe hypertension stages.

As with any lifestyle change, it should be personalized to and guided by a healthcare provider particularly if you have severe high blood pressure or are taking more than one medication.

Long considered a standard tool for assessing body weight, Body Mass Index (BMI) may not be as reliable as once believed. A new study shows that relying on BMI can incorrectly classify people as overweight or obese.

When a team of Italian researchers used the gold standard technique of dual-energy X-ray absorptiometry (DXA) to measure body fat in the general population, they found that the traditional WHO-approved BMI classification system misidentified a significant number of people as having overweight or obesity.

How Is The BMI Wrong?

A total of 1,351 adults of mixed gender aged between 18 and 98 years were checked for their body weight using the DXA system.

The results, published in the journal Nutrients, revealed that more than one-third (34 percent) of those with obesity defined by BMI had been misclassified and should be in the overweight category.

For those with an overweight BMI, DXA showed that more than half – 53 percent – had been misclassified – three quarters of those misclassified fall into the normal weight category, while the other quarter should have been classified as having obesity.

The DXA analysis found that the prevalence of overweight and obesity across the cohort was around 37 percent overall (23.4 percent overweight, and 13.2 percent obesity, compared to 26.2 percent and 14.1 percent with BMI).

“In the past few years, there has been a lot of criticism of the BMI system due to its inability to accurately capture body fat percentage or distribution, to correctly categorise weight status based on adiposity,” said Professor Marwan El Ghoch, of the Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Also read: Your BMI Does Not Reflect Your Health: New Study Warns How It Misses A Key Health Aspect

Despite these concerns, BMI as a weight classification system continues to be used in the general population in primary healthcare (i.e., general practitioners) and non-clinical (i.e., policy and health insurance) settings, he added.

The researchers urged revising public health guidelines to consider combining direct body composition or their surrogate measures, such as skinfold measurement or body circumference, with the waist-to-height ratio, with BMI, while assessing weight status in the general population.

Waist-to-Height Ratio May Be More Accurate: The India Story

In January 2025, India revamped its obesity guidelines, and the new approach focused on abdominal obesity and comorbid diseases, rather than just BMI.

According to the redefining team, it was essential to move beyond BMI-only approaches to tackle the ever-growing number of people related to other major health risks. They stated that while BMI can be a screening tool, obesity must be defined by body fat.

“BMI should be used for screening purposes, but obesity should be confirmed ideally by a measure of body fat wherever feasible, or another measure such as waist circumference, WHR, or Waist-to-height ratio,” Dr. Naval Vikram, Professor of Medicine, at AIIMS, New Delhi, was quoted as saying to IANS at the time.

Also read: 41 million children aged 5-19 living with high BMI in India: Study

What Do The New Guidelines Say

It recognizes abdominal fat — closely linked to insulin resistance — as a key factor in the diagnosis. It integrates the presence of comorbidities — such as diabetes and cardiovascular disease — into the diagnostic process.

The revised guidelines also introduce a two-stage classification system, addressing both generalized and abdominal obesity.

Stage 1 Obesity: Increased adiposity (BMI > 23 kg/m²) without apparent effects on organ functions or routine daily activities.

Stage 2 Obesity: Advanced state of obesity with increased BMI more than 23 kg/2, and abdominal adiposity; excess Waist Circumference or Waist-to-Height Ratio.

Amanda Peet, the Hollywood actress known for roles in Something’s Gotta Give, The Whole Nine Yards, and Jack & Jill, recently opened up about her breast cancer diagnosis and how informing her kids about her health became the toughest part for her.

In a New Yorker essay published March 21, the 54-year-old actress announced how a routine scan in August 2025 showed an unusual ultrasound result. Later, a biopsy detected a tumor that “appeared” small.

The Dirty John star found to be in stage 1 of lobular cancer that is “hormone-receptor-positive” and “HER2-negative,” making her “happier than the pre-diagnosis” stage.

It is because Hormone-receptor-positive and HER2-negative cancer is less aggressive and often easier to treat than more aggressive forms of breast cancer.

However, informing her children, Frances, 19, Molly, 15, and Henry, 11, about the cancer was the toughest part for her, and she had to be in the right mindset before sharing the news with them.

“They've been great,” Peet told E! News.

“I definitely had to get myself together before including them. The hard part was realizing that nothing is certain and there was going to be no perfect time to tell them,” she added.

Peet stated that between her diagnosis, she had also been navigating a series of family health crises — with both of her parents' final months in hospice care.

The Your Friends & Neighbors actress, in her essay, also noted that she would “only need a lumpectomy and radiation,” not a double mastectomy.

Also read: Jane Fallon Diagnosed With Breast Cancer, This Is How She Caught It Early

What is Lobular Cancer?

Invasive Lobular Carcinoma (ILC) the second most common form of breast cancer, representing 5 to 15 percent of breast cancer cases.

Rather than a distinct lump, it can appear as a thickening or "fullness" rather than a tumor.

It is often difficult to detect on mammograms, thus MRI or ultrasound are more effective for detection

It is usually hormone receptor-positive.

Also read: Olivia Munn’s Mom Diagnosed With Breast Cancer After Actor Urges Her To Take Risk Test; What Should You Do If Cancer Runs In Your Family?

What Is Hormone receptor-positive (HR+) and HER2-negative (HER2−) Breast Cancer

HR+ and HER2− breast cancer is the most common subtype and is seen among 60–75 per cent of cases.

It is not two different cancers, but rather specific, defining characteristics of the same cancer type (breast cancer). It grows:

• due to hormones estrogen/progesterone,
• lacks excess HER2 protein,
• it can occur in either or both breasts
• has a better prognosis
• slower growth rate
• often treated with hormone therapy and sometimes chemotherapy.

Why Early Diagnosis Matters for Breast Cancer

According to the Centers for Disease Control and Prevention (CDC), breast cancer screening is a proactive checkup used to find cancer before any physical signs or symptoms appear. While screening doesn’t prevent cancer, its goal is early detection, making the disease much easier to treat.

Since every person’s body and history are different, you and your doctor should engage in informed and shared decision-making. This means discussing the pros and cons to decide together if, and when, screening is right for you.

The US Preventive Services Task Force (a group of national medical experts) provides guidelines based on the latest research:

Average Risk

Women aged 40 to 74 should generally get a mammogram every two years.

High Risk

If you have a family history or other risk factors, your doctor may recommend a different schedule or additional tests.

GLP-1 receptor agonists are a modern class of medicines that have changed the treatment of type 2 diabetes and obesity. In simple terms, they help the body respond to food more smartly. After eating, the intestine naturally sends signals that help regulate sugar and appetite levels.

GLP-1 RA medicines imitate this signal. As a result, blood sugar rises less after meals, appetite becomes more controlled, and many people feel full with smaller amounts of food. This is why these medicines are used not only for diabetes, but also for weight reduction in selected people.

GLP-1 Drugs: Not A Miracle Injection

These medicines are important because their benefits can go beyond sugar control alone. Studies and current diabetes guidelines show that some GLP-1 RAs can reduce body weight, improve long-term sugar levels, and lower the risk of major heart-related problems in people who have type 2 diabetes and high cardiovascular risk.

Recent guidance also supports their use in some people with chronic kidney disease when cardiovascular risk reduction is an important goal. This does not mean every drug in the group is identical, but it means the class has become medically important for more than just lowering sugar.

For the general public, one important point is that these are not “miracle injections.”

They work best when combined with better food choices, regular walking or exercise, good sleep, and medical follow-up. They are usually started slowly because the commonest side effects are stomach-related, such as nausea, vomiting, constipation, loose motions, or a feeling of fullness.

Not everyone is suitable for them, and the decision depends on a person’s diabetes status, weight, heart or kidney disease, other medicines, and cost. Used properly, GLP-1 RAs are powerful tools that can improve health, but they should always be taken under medical supervision.

GLP-1 Drugs: Urgent Need to Curb Misuse

So Indian Medical Association (IMA) is planning to seek a mandate restricting prescriptions of GLP-1 drugs to certified endocrinologists/diabetologists or MD general medicine practitioners to curb indiscriminate use and safeguard patient safety as access expands, many media report in August last year about rampant misuse of GLP1 weight loss drugs by cosmetologists, physiotherapists, dermatologists, general MBBS clinicians, and even ayurveda, and other non-modern medicine practitioners.

Many MBBS, physiotherapists, and non-modern medicine practitioners are prescribing GLP1 drugs to people who neither have diabetes nor any comorbidity or acute obesity, but purely for cosmetic reasons to lose some weight that can be otherwise easily done with some lifestyle changes like exercise and diet.

It is a duty of the government to take care of it because there is a lot of misuse and misprescription that needs to be curbed immediately, because these medicines also have side effects.

We will write to the government to take necessary action to stop the misuse of the drug. We will discuss it in our meeting in the first week of April 2026.